Adverse anaphilactoid reaction of oxaloplatin

[1]  K. Paull,et al.  Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. , 1996, Biochemical pharmacology.

[2]  M. Espié,et al.  Phase I study of oxaliplatin in patients with advanced cancer , 2004, Cancer Chemotherapy and Pharmacology.

[3]  R. Labianca,et al.  Idiosyncratic reaction after oxaliplatin infusion. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  J. Misset,et al.  A phase I trial of trans-1-diaminocyclohexane oxalato-platinum (l-OHP). , 1986, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.